HALLAND; Nis

Patent Applications and Registrations

Patent applications and USPTO patent grants for HALLAND; Nis.The latest application filed is for "novel conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein".

Company Profile

1.18.20

HALLAND; Nis - Frankfurt am Main DE
Halland; Nis - Frankfurt DE
Halland; Nis - Bad Soden DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Conjugates Of A Pharmaceutical Agent And A Moiety Capable Of Binding To A Glucose Sensing Protein App 20210170033 - PETRY; Stefan ; et al.	2021-06-10
Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 10,392,366 - Schwink , et al. A	2019-08-27
Azetidine Compounds As Grp119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20180237419 - Schwink; Lothar ; et al.	2018-08-23
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,908,868 - Schwink , et al. March 6, 2	2018-03-06
Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,896,434 - Schwink , et al. February 20, 2	2018-02-20
Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Grant 9,758,520 - Schwink , et al. September 12, 2	2017-09-12
N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals Grant 9,718,825 - Nazare , et al. August 1, 2	2017-08-01
Substituted Indanone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170029405 - SCHWINK; Lothar ; et al.	2017-02-02
Substituted Fused Heterocycles As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170022198 - SCHWINK; Lothar ; et al.	2017-01-26
Isoindolinone Compounds As Gpr119 Modulators For The Treatment Of Diabetes, Obesity, Dyslipidemia And Related Disorders App 20170022182 - SCHWINK; Lothar ; et al.	2017-01-26
N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS App 20160175304 - NAZARE; Marc ; et al.	2016-06-23
N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides And Their Use As Pharmaceuticals App 20160024097 - NAZARE; Marc ; et al.	2016-01-28
N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals Grant 9,221,828 - Nazare , et al. December 29, 2	2015-12-29
N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals Grant 9,174,993 - Nazare , et al. November 3, 2	2015-11-03
N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides And Their Use As Pharmaceuticals App 20140357640 - Nazare; Marc ; et al.	2014-12-04
N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides And Their Use As Pharmaceuticals App 20140288083 - Nazare; Marc ; et al.	2014-09-25
Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles Grant 8,735,586 - Alonso , et al. May 27, 2	2014-05-27
Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates Grant 8,487,109 - Rkyek , et al. July 16, 2	2013-07-16
Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates Grant 8,420,812 - Rkyek , et al. April 16, 2	2013-04-16
N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS App 20130072493 - NAZARE; Marc ; et al.	2013-03-21
Urea and sulfamide derivatives as inhibitors of TAFIa Grant 8,389,764 - Kallus , et al. March 5, 2	2013-03-05
Transition metal catalyzed synthesis of 2H-indazoles Grant 8,283,476 - Halland , et al. October 9, 2	2012-10-09
Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles Grant 8,188,282 - Alonso , et al. May 29, 2	2012-05-29
Transition metal catalyzed synthesis of N-aminoindoles Grant 8,026,375 - Halland , et al. September 27, 2	2011-09-27
Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates App 20100261910 - RKYEK; Omar ; et al.	2010-10-14
Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles App 20100261909 - ALONSO; Jorge ; et al.	2010-10-14
Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates App 20100261900 - RKYEK; Omar ; et al.	2010-10-14
Transition metal catalyzed synthesis of 2H-indazoles App 20100234601 - HALLAND; Nis ; et al.	2010-09-16
Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles App 20100216988 - ALONSO; Jorge ; et al.	2010-08-26
Transition metal catalyzed synthesis of N-aminoindoles App 20100168429 - HALLAND; Nis ; et al.	2010-07-01
UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa App 20100035930 - KALLUS; Christopher ; et al.	2010-02-11
Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles App 20090203912 - ALONSO; Jorge ; et al.	2009-08-13
Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds App 20070276142 - Halland; Nis ; et al.	2007-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.